We are live on
!
Find out more
CCM
Camber Capital Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
8.19%
This Fund
S&P 500
This Quarter
Est. Return
+13.67%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$3.92B
AUM Growth
+$890M
(+29%)
Cap. Flow
+$570M
Cap. Flow
% of AUM
14.53%
Top 10 Holdings %
Top 10 Hldgs %
70.03%
Holding
46
New
6
Increased
11
Reduced
10
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$84.2M |
| 2 |
Baxter International
BAX
|
+$70.8M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$40.2M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$34.9M |
| 5 |
Medtronic
MDT
|
+$26.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$148M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$104M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$66.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$65.3M |
| 5 |
Dentsply Sirona
XRAY
|
+$60.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 70.63% |
| 2 | Consumer Staples | 1.06% |
| 3 | Consumer Discretionary | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Peloton Interactive
PTON
$2.45B
| $27.4M | 0.7% |
4,500,000
| – | – |
|
27
Qiagen
QGEN
$8.67B
| $26.7M | 0.68% |
579,979
+202,757
| +54% | +$8.62M |
|
28
Moderna
MRNA
$22.9B
| $24.9M | 0.63% |
+250,000
| New | +$21M |
|
29
Harmony Biosciences
HRMY
$2.27B
| $24.2M | 0.62% |
+750,000
| New | +$20.9M |
|
30
Ascendis Pharma A/S
ASND
$16.6B
| $20.8M | 0.53% |
+165,000
| New | +$16.5M |
|
|
BKDT
31
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| $20.3M | 0.52% |
250,000
| – | – |
|
32
Puma Biotechnology
PBYI
$432M
| $12.1M | 0.31% |
2,805,000
-1,430,000
| -34% | -$4.74M |
|
33
Inogen
INGN
$164M
| $11M | 0.28% |
2,000,000
| – | – |
|
34
SkinHealth Systems
SKIN
$88.2M
| $10.9M | 0.28% |
3,500,000
-1,500,000
| -30% | -$5.63M |
|
35
Solid Biosciences
SLDB
$836M
| $8.71M | 0.22% |
1,418,439
| – | – |
|
36
Replimune Group
REPL
$1.03B
| $8.43M | 0.21% |
1,000,000
-1,000,000
| -50% | -$11.6M |
|
|
BCYC
37
Bicycle Therapeutics
BCYC
$289M
| $8.14M | 0.21% |
450,000
+50,000
| +13% | +$827K |
|
|
CVAC
38
DELISTED
CureVac
CVAC
| $7.37M | 0.19% |
1,750,000
| – | – |
|
39
BioMarin Pharmaceuticals
BMRN
$12.3B
| – | – |
-300,000
| Closed | -$26.5M |
|
40
Exelixis
EXEL
$13.2B
| – | – |
-300,000
| Closed | -$6.55M |
|
41
Quanterix
QTRX
$187M
| – | – |
-1,275,000
| Closed | -$34.6M |
|
|
42
Sanofi
SNY
$105B
| – | – |
-2,750,000
| Closed | -$148M |
|
|
43
Teva Pharmaceuticals
TEVA
$41.1B
| – | – |
-10,150,000
| Closed | -$104M |
|
|
44
Dentsply Sirona
XRAY
$2.43B
| – | – |
-1,765,000
| Closed | -$60.3M |
|
|
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-1,500,000
| Closed | -$65.3M |
|
|
CANO
46
DELISTED
Cano Health, Inc.
CANO
| – | – |
-40,000
| Closed | -$1.01M |
|
Similar funds
PP
SAF
NRD
FC
GIM
SC
BWA
CCP
Camber Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Camber Capital Management held 46 positions worth $3.92B, up 29% from $3.03B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Camber Capital Management deployed $570M of net new capital in Q4 2023, opening 6 new positions and adding to 11 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 675,000 shares worth $83M.
By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 88% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $66.3M trimmed.
- Camber Capital Management's largest Q4 2023 buy was Jazz Pharmaceuticals: 675,000 shares worth $83M.
- Camber Capital Management added most to Baxter International in Q4 2023, an estimated $70.8M increase.
- Camber Capital Management's biggest Q4 2023 reduction was Ionis Pharmaceuticals, cutting an estimated $66.3M.
- Camber Capital Management fully exited Sanofi in Q4 2023, selling an estimated $148M.
- Camber Capital Management's ten largest holdings make up 70% of its $3.92B portfolio in Q4 2023.
- Camber Capital Management opened 6 new positions and closed 8 in Q4 2023.
- Camber Capital Management's portfolio value rose 29% quarter-over-quarter to $3.92B.
Based on Camber Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.